HEADER STRUCTURAL GENOMICS, UNKNOWN FUNCTION 29-JUN-07 2QGU TITLE THREE-DIMENSIONAL STRUCTURE OF THE PHOSPHOLIPID-BINDING PROTEIN FROM TITLE 2 RALSTONIA SOLANACEARUM Q8XV73_RALSQ IN COMPLEX WITH A PHOSPHOLIPID AT TITLE 3 THE RESOLUTION 1.53 A. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TITLE 4 TARGET RSR89 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROBABLE SIGNAL PEPTIDE PROTEIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RALSTONIA SOLANACEARUM; SOURCE 3 ORGANISM_TAXID: 267608; SOURCE 4 STRAIN: GMI1000; SOURCE 5 GENE: RSC2958; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS NESG, RSR89, Q8XV73, STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE KEYWDS 2 INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, UNKNOWN KEYWDS 3 FUNCTION EXPDTA X-RAY DIFFRACTION AUTHOR A.P.KUZIN,Y.CHEN,S.JAYARAMAN,C.X.CHEN,Y.FANG,K.CUNNINGHAM,L.-C.MA, AUTHOR 2 R.XIAO,J.LIU,M.C.BARAN,T.B.ACTON,B.ROST,G.T.MONTELIONE,J.F.HUNT, AUTHOR 3 L.TONG,NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) REVDAT 7 20-NOV-24 2QGU 1 REMARK REVDAT 6 20-OCT-21 2QGU 1 REMARK SEQADV LINK REVDAT 5 24-JAN-18 2QGU 1 AUTHOR JRNL REVDAT 4 13-JUL-11 2QGU 1 VERSN REVDAT 3 24-FEB-09 2QGU 1 VERSN REVDAT 2 09-OCT-07 2QGU 1 TITLE REVDAT 1 24-JUL-07 2QGU 0 JRNL AUTH A.P.KUZIN,Y.CHEN,S.JAYARAMAN,C.X.CHEN,Y.FANG,K.CUNNINGHAM, JRNL AUTH 2 L.-C.MA,R.XIAO,J.LIU,M.C.BARAN,T.B.ACTON,B.ROST, JRNL AUTH 3 G.T.MONTELIONE,J.F.HUNT,L.TONG JRNL TITL THREE-DIMENSIONAL STRUCTURE OF THE PHOSPHOLIPID-BINDING JRNL TITL 2 PROTEIN FROM RALSTONIA SOLANACEARUM Q8XV73_RALSQ IN COMPLEX JRNL TITL 3 WITH A PHOSPHOLIPID AT THE RESOLUTION 1.53 A. JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.95 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 33037 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.187 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.211 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1750 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.54 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2073 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.1630 REMARK 3 BIN FREE R VALUE SET COUNT : 107 REMARK 3 BIN FREE R VALUE : 0.2000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1398 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 47 REMARK 3 SOLVENT ATOMS : 356 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 14.24 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.28000 REMARK 3 B22 (A**2) : 0.40000 REMARK 3 B33 (A**2) : -0.12000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.076 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.076 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.040 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.010 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.948 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.931 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1516 ; 0.006 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2051 ; 1.020 ; 1.970 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 188 ; 4.600 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 73 ;35.076 ;24.658 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 253 ;11.053 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ;16.133 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 225 ; 0.068 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1160 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 720 ; 0.191 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1049 ; 0.303 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 247 ; 0.085 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 30 ; 0.136 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 39 ; 0.162 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 940 ; 0.527 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1485 ; 0.887 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 640 ; 1.557 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 566 ; 2.552 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 29 A 29 REMARK 3 ORIGIN FOR THE GROUP (A): 16.5380 19.7580 72.3780 REMARK 3 T TENSOR REMARK 3 T11: -0.0391 T22: -0.0574 REMARK 3 T33: -0.0285 T12: 0.0109 REMARK 3 T13: 0.0029 T23: -0.0036 REMARK 3 L TENSOR REMARK 3 L11: 0.7692 L22: 0.7277 REMARK 3 L33: 1.5544 L12: 0.1428 REMARK 3 L13: 0.3084 L23: -0.0324 REMARK 3 S TENSOR REMARK 3 S11: -0.0190 S12: -0.0299 S13: 0.0607 REMARK 3 S21: 0.0622 S22: 0.0032 S23: -0.0174 REMARK 3 S31: -0.0670 S32: 0.0069 S33: 0.0157 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2QGU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-JUL-07. REMARK 100 THE DEPOSITION ID IS D_1000043581. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-APR-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X4A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97900 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34787 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.5 REMARK 200 DATA REDUNDANCY : 9.100 REMARK 200 R MERGE (I) : 0.05300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 25.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.55 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.15200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 7.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SNB REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.84 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS-HCL, 25% W/V PEG6000, 0.1M REMARK 280 TRIMETHYLAMINE, 10% GLYCEROL, PH 8.5, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.24750 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 58.75400 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 23.23900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 58.75400 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.24750 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 23.23900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MSE A 1 REMARK 465 PHE A 2 REMARK 465 LYS A 3 REMARK 465 LYS A 4 REMARK 465 LEU A 5 REMARK 465 LEU A 6 REMARK 465 HIS A 7 REMARK 465 SER A 8 REMARK 465 LEU A 9 REMARK 465 VAL A 10 REMARK 465 ALA A 11 REMARK 465 GLY A 12 REMARK 465 LEU A 13 REMARK 465 THR A 14 REMARK 465 PHE A 15 REMARK 465 VAL A 16 REMARK 465 ALA A 17 REMARK 465 ALA A 18 REMARK 465 VAL A 19 REMARK 465 ALA A 20 REMARK 465 ALA A 21 REMARK 465 VAL A 22 REMARK 465 PRO A 23 REMARK 465 ALA A 24 REMARK 465 HIS A 25 REMARK 465 ALA A 26 REMARK 465 GLN A 27 REMARK 465 GLU A 28 REMARK 465 GLY A 208 REMARK 465 PRO A 209 REMARK 465 ALA A 210 REMARK 465 LYS A 211 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 117 -62.43 -134.51 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 AUTHORS STATE THAT THERE IS NO CHEMICAL CONFIRMATION REMARK 600 WHETHER THE LIGAND PRESENT IN THE STRUCTURE IS PEA REMARK 600 OR PEF. THE LIGAND CAME FROM THE BACTERIAL EXPRESSION REMARK 600 AND ITS ASSIGNMENT HAS BEEN MADE BASED ON THE 3-D REMARK 600 STRUCTURE. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEF A 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: RSR89 RELATED DB: TARGETDB DBREF 2QGU A 1 211 UNP Q8XV73 Q8XV73_RALSO 1 211 SEQADV 2QGU MSE A 1 UNP Q8XV73 MET 1 MODIFIED RESIDUE SEQADV 2QGU VAL A 10 UNP Q8XV73 PHE 10 ENGINEERED MUTATION SEQADV 2QGU VAL A 16 UNP Q8XV73 MET 16 ENGINEERED MUTATION SEQADV 2QGU ALA A 33 UNP Q8XV73 THR 33 ENGINEERED MUTATION SEQADV 2QGU PRO A 50 UNP Q8XV73 SER 50 ENGINEERED MUTATION SEQADV 2QGU GLY A 54 UNP Q8XV73 SER 54 ENGINEERED MUTATION SEQADV 2QGU LEU A 57 UNP Q8XV73 MET 57 ENGINEERED MUTATION SEQADV 2QGU MSE A 82 UNP Q8XV73 MET 82 MODIFIED RESIDUE SEQADV 2QGU SER A 103 UNP Q8XV73 THR 103 ENGINEERED MUTATION SEQADV 2QGU ILE A 106 UNP Q8XV73 VAL 106 ENGINEERED MUTATION SEQADV 2QGU ALA A 122 UNP Q8XV73 SER 122 ENGINEERED MUTATION SEQADV 2QGU VAL A 154 UNP Q8XV73 MET 154 ENGINEERED MUTATION SEQADV 2QGU PRO A 158 UNP Q8XV73 ALA 158 ENGINEERED MUTATION SEQADV 2QGU ASP A 183 UNP Q8XV73 GLU 183 ENGINEERED MUTATION SEQADV 2QGU GLY A 192 UNP Q8XV73 SER 192 ENGINEERED MUTATION SEQRES 1 A 211 MSE PHE LYS LYS LEU LEU HIS SER LEU VAL ALA GLY LEU SEQRES 2 A 211 THR PHE VAL ALA ALA VAL ALA ALA VAL PRO ALA HIS ALA SEQRES 3 A 211 GLN GLU ALA ASP ALA GLN ALA THR VAL LYS THR ALA VAL SEQRES 4 A 211 ASP ASP VAL LEU ALA THR ILE LYS GLY ASP PRO ASP LEU SEQRES 5 A 211 ARG GLY GLY ASN LEU GLN LYS VAL PHE GLN LEU VAL ASP SEQRES 6 A 211 GLN LYS ILE VAL PRO ARG ALA ASP PHE LYS ARG THR THR SEQRES 7 A 211 GLN ILE ALA MSE GLY ARG PHE TRP SER GLN ALA THR PRO SEQRES 8 A 211 GLU GLN GLN GLN GLN ILE GLN ASP GLY PHE LYS SER LEU SEQRES 9 A 211 LEU ILE ARG THR TYR ALA GLY ALA LEU ALA ASN VAL ARG SEQRES 10 A 211 ASN GLN THR VAL ALA TYR LYS PRO PHE ARG ALA ALA ALA SEQRES 11 A 211 ASP ASP THR ASP VAL VAL VAL ARG SER THR VAL ASN ASN SEQRES 12 A 211 ASN GLY GLU PRO VAL ALA LEU ASP TYR ARG VAL GLU LYS SEQRES 13 A 211 SER PRO ASN GLY TRP LYS VAL TYR ASP ILE ASN ILE SER SEQRES 14 A 211 GLY LEU TRP LEU SER GLU THR TYR LYS ASN GLN PHE ALA SEQRES 15 A 211 ASP VAL ILE SER LYS ARG GLY GLY VAL GLY GLY LEU VAL SEQRES 16 A 211 GLN PHE LEU ASP GLU ARG ASN ALA GLN LEU ALA LYS GLY SEQRES 17 A 211 PRO ALA LYS MODRES 2QGU MSE A 82 MET SELENOMETHIONINE HET MSE A 82 16 HET PEF A 301 47 HETNAM MSE SELENOMETHIONINE HETNAM PEF DI-PALMITOYL-3-SN-PHOSPHATIDYLETHANOLAMINE HETSYN PEF 3-[AMINOETHYLPHOSPHORYL]-[1,2-DI-PALMITOYL]-SN-GLYCEROL FORMUL 1 MSE C5 H11 N O2 SE FORMUL 2 PEF C37 H74 N O8 P FORMUL 3 HOH *356(H2 O) HELIX 1 1 ASP A 30 GLY A 48 1 19 HELIX 2 2 ASP A 49 GLY A 54 1 6 HELIX 3 3 ASN A 56 ILE A 68 1 13 HELIX 4 4 VAL A 69 ALA A 72 5 4 HELIX 5 5 ASP A 73 GLY A 83 1 11 HELIX 6 6 ARG A 84 TRP A 86 5 3 HELIX 7 7 THR A 90 ASN A 115 1 26 HELIX 8 8 LEU A 173 GLY A 189 1 17 HELIX 9 9 GLY A 190 LYS A 207 1 18 SHEET 1 A 5 THR A 120 TYR A 123 0 SHEET 2 A 5 ASP A 134 ASN A 143 -1 O ASN A 142 N THR A 120 SHEET 3 A 5 GLU A 146 SER A 157 -1 O VAL A 148 N VAL A 141 SHEET 4 A 5 GLY A 160 ILE A 168 -1 O GLY A 160 N SER A 157 SHEET 5 A 5 LEU A 171 TRP A 172 -1 O LEU A 171 N ILE A 168 LINK C ALA A 81 N AMSE A 82 1555 1555 1.33 LINK C ALA A 81 N BMSE A 82 1555 1555 1.33 LINK C BMSE A 82 N GLY A 83 1555 1555 1.33 LINK C AMSE A 82 N GLY A 83 1555 1555 1.33 SITE 1 AC1 16 TYR A 109 ALA A 112 GLN A 119 ARG A 127 SITE 2 AC1 16 ASP A 131 ARG A 138 ASN A 143 TYR A 152 SITE 3 AC1 16 ILE A 168 HOH A 311 HOH A 365 HOH A 398 SITE 4 AC1 16 HOH A 410 HOH A 422 HOH A 556 HOH A 634 CRYST1 42.495 46.478 117.508 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023532 0.000000 0.000000 0.00000 SCALE2 0.000000 0.021516 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008510 0.00000